Filing Details
- Accession Number:
- 0001209191-20-019005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-13 17:41:46
- Reporting Period:
- 2020-03-12
- Accepted Time:
- 2020-03-13 17:41:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1331852 | S Joseph Zakrzewski | C/O Sangamo Therapeautics, Inc. 7000 Marina Blvd Brisbane CA 94005 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-12 | 15,000 | $6.31 | 20,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2020-03-13 | 5,000 | $5.67 | 25,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- Includes 2,500 shares of common stock subject to restricted stock units ("RSUs") granted on June 10, 2019. The RSUs will fully vest on the earlier of (x) June 10, 2020 (the first anniversary of the date of grant) or (y) the day prior to Issuer's 2020 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such dates.
Billionaire Hedge Funds
